These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6853065)
41. [Glucocorticoids for dermatologic disorders]. Kitajima Y Nihon Rinsho; 1994 Mar; 52(3):754-9. PubMed ID: 8164378 [TBL] [Abstract][Full Text] [Related]
42. UK national survey of current practice and experience of intravitreal triamcinolone acetonide. Jain S; Hurst JR; Thompson JR; Eke T Eye (Lond); 2009 May; 23(5):1164-7. PubMed ID: 18551135 [TBL] [Abstract][Full Text] [Related]
43. Management of the flat anterior chamber after cataract surgery. Soll DB Ann Ophthalmol; 1971 Feb; 3(2):201-2 p. PubMed ID: 4950681 [No Abstract] [Full Text] [Related]
44. Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid. Comstock TL; Sheppard JD Expert Opin Pharmacother; 2018 Mar; 19(4):337-353. PubMed ID: 29430976 [TBL] [Abstract][Full Text] [Related]
49. [How to use glucocorticoids in ophthalmology]. Fujiwara T Nihon Rinsho; 1994 Mar; 52(3):760-6. PubMed ID: 8164379 [TBL] [Abstract][Full Text] [Related]
50. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs. Holland MG Ann Ophthalmol; 1974 May; 6(5):447-50 passim. PubMed ID: 4208894 [No Abstract] [Full Text] [Related]
51. The use of corticosteroids to treat ocular inflammation. Holmberg BJ; Maggs DJ Vet Clin North Am Small Anim Pract; 2004 May; 34(3):693-705. PubMed ID: 15110979 [TBL] [Abstract][Full Text] [Related]
52. [New aspects on systemic adverse effects of ocular drugs]. Uusitalo H; Salminen L Duodecim; 1998; 114(3):287-92. PubMed ID: 10895504 [No Abstract] [Full Text] [Related]
53. Cataract surgery after intravitreal injection of triamcinolone acetonide. Jonas JB; Kreissig I; Degenring RF Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430 [TBL] [Abstract][Full Text] [Related]
54. Ocular inflammatory disease: use of topical and systemic anti-inflammatory agents. Tessler HH Manag Care; 2002 Jan; 11(1 Suppl):12-5; discussion 24-7. PubMed ID: 11842586 [No Abstract] [Full Text] [Related]
55. Effects of glucocorticosteroids on the skin and eye. Beltrani VS; Barsanti FA; Bielory L Immunol Allergy Clin North Am; 2005 Aug; 25(3):557-80. PubMed ID: 16054543 [TBL] [Abstract][Full Text] [Related]
56. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide. Mahar PS; Memon AS J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849 [TBL] [Abstract][Full Text] [Related]
57. The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. Mueller AJ; Jian G; Banker AS; Rahhal FM; Capparelli E; Freeman WR Am J Ophthalmol; 1998 Feb; 125(2):158-63. PubMed ID: 9467440 [TBL] [Abstract][Full Text] [Related]
58. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS. Reid GA; Sahota DS; Sarhan M Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545 [TBL] [Abstract][Full Text] [Related]
59. Juvenile xanthogranulomatosis with bilateral and multifocal ocular lesions of the iris, cornealscleral limbus, and choroid. Longmuir S; Dumitrescu A; Kwon Y; Boldt HC; Hong S J AAPOS; 2011 Dec; 15(6):598-600. PubMed ID: 22153409 [TBL] [Abstract][Full Text] [Related]
60. [Allergic rhinitis. Topical steroids without systemic effect]. Maegele M Med Monatsschr Pharm; 1999 Mar; 22(3):89-90. PubMed ID: 10223869 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]